
<DOC>
<DOCNO>
WSJ901231-0067
</DOCNO>
<DOCID>
901231-0067.
</DOCID>
<HL>
   Business Brief -- IVAX Corp.:
   Miami Company Acquires
   Harris Pharmaceuticals Ltd.
</HL>
<DATE>
12/31/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE 30
</SO>
<CO>
   IVX
</CO>
<IN>
DRUG MANUFACTURERS (DRG)
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
</IN>
<LP>
   IVAX Corp. said it completed the acquisition of Harris
Pharmaceuticals Ltd. for 6,250,000 common shares in a
transaction valued at $73.4 million.
   Harris makes and markets generic pharmaceuticals and has
facilities in London and Waterford, Ireland. Miami-based IVAX
is a holding company with interests in pharmaceuticals and
medical diagnostics. Three operating officers of Harris-Isaac
Kaye, Cyril Beck and Nigel Nortonwere appointed to IVAX's
board.
</LP>
<TEXT>
</TEXT>
</DOC>